The Italian Medicines Agency (Agenzia Italiana del Farmaco, AIFA) announced on 15 January 2021 the update of its Transparency Lists (liste di trasparenza).
- INICIO
-
Genéricos
Novedades
- US generics launch and approval for Dr Reddy’s and Lupin
- Five Chinese companies join UN’s MPP for Covid-19 medicines
- South Korean companies to make generic Bridion and COVID-19 drugs
- Revlimid (lenalidomide) generics launch across Europe
-
Biosimilares
Novedades
- Clinical study advances for Alvotech golimumab and Dr Reddy’s rituximab biosimilars
- New insulin glargine and potential adalimumab interchangeable biosimilars
- Biosimilar advances for Alvotech-Teva and setback for Biocon Biologics
- Advances for Bio-Thera’s secukinumab and mepolizumab copy biologicals
Investigación
- Best-value biological selection making: more to consider than only price
- EE.UU. frente a Alemania y Suiza: El mercado estadounidense de biosimilares se queda atrás con precios más altos
- Drug survival of adalimumab biosimilars in psoriasis treatment in Spain
- Pegfilgrastim biosimilars in US supportive oncology
General
- US PBMs add multiple Humira biosimilars to formularies
- Canada’s Ontario introduces biosimilars switching policy
- Hechos clave en la regulación de la aprobación de biosimilares en Brasil
- La provincia canadiense de Saskatchewan introduce una política de switching de biosimilares
- MORE EDITORIAL SECTIONS
- Search
Post your comment